ClearSight LLC is a pioneering company based in Aurora, CO that has developed the ClearSight Intraocular Lens (IOL), a revolutionary device designed to address posterior capsule opacification (PCO) in cataract patients. The ClearSight IOL features Sharklet, a micropattern that redirects cellular migration away from the field of vision, preventing clouding of the lens. With its versatile platform, anti-glistening material, and innovative design, ClearSight IOL offers a comprehensive solution for ophthalmologists and maximum patient satisfaction. Led by Chairman of the Board of Directors, Dr. Khalid Mentak, a renowned expert in the ophthalmic field, ClearSight LLC is at the forefront of medical device innovation. Driven by a commitment to developing and licensing novel technologies for ophthalmic applications, the company aims to improve visual outcomes and reduce the occurrence of PCO through their groundbreaking ClearSight IOL. With extensive experience in building medical device companies, Dr. Mentak's leadership ensures that ClearSight LLC remains at the cutting edge of ophthalmic advancements.
Generated from the website